2024

Jan. The 1st TFDA SaMD Approval- MetaLite DX Digital Pathology Software

2023

Oct. 1220P Comprehensive diagnose of programmed death-ligand 1 from two-dimensional to three-dimensional in breast cancer with computer-aided artificial intelligence system – Annals of Oncology

Sep. TFDA approval- Medical Device Quality Management System

Jun. Publication in Laboratory Investigation- Panoramic Tissue Examination That Integrates 3-Dimensional Pathology Imaging and Gene Mutation: Potential Utility in Non-Small Cell Lung Cancer

Mar. JelloX Biotech Opens New Horizons for AI-Powered 3D Pathology

Feb.3D pathology for lupus nephritis interstitial inflammation diagnosis

2022

Dec. FDA ISO13485:2016 Certificate

Dec. H. Spectrum+ Rising Star Award

Dec. Intel-Roche Diagnostic Taiwan-JelloX Biotech forming Digital Pathology Industry Alliance to promote next generation pathology

Nov. JelloX Biotech CEO Yen-Yin Lin won the third prize of 2022 Best Bio Startup CEO

Oct.  Publication in Frontiers in Oncology- A domain knowledge enhanced yield based deep learning classifier identifies perineural invasion in oral cavity squamous cell carcinoma

Oct.  Precision diagnosis of nerve invasion in oral cancer with Domain-KEY AI model

Oct. JelloX Biotech is recommended by Hsinchu Biomedical Science Park to share new business opportunities in next generation digital pathology total solution

Oct. JelloX Biotech is awarded as new members of H. Spectrum Accelerator sponsored by Foxconn Technology Co.,Ltd.  Deeper collaboration in domestic resources and international ecosystem is ongoing

Sep. Exhibition in Intel Innovation @ USA as APAC digital health representative

Sep.  Oral presentation of precision medicine session in Taiwan-Japan Science and Technology Forum

Sep. Publication in ECP2022-3D biomarker expression and genetic alterations in NSCLC

Sep. Publication in ECP2022-3D diagnosis of HER2 expression-low breast cancers

Aug. Publication in J. Histochemistry & Cytochemistry 2022-Prostate cancer 3D morphology and Gleason scoring

Apr. Publication in J. Translational Medicine-Lung cancer 3D PD-L1 profiling and TPS evaluation

Apr.  Recognition as Intel Market Ready Solution

Apr. TW patent issued-I761016

Mar. Get DUNS Registered™ Certificate

Mar. Boehringer Ingelheim’s Grass Roots Initiative Award

Jan. Deep-learning based breast cancer detection for cross-staining histopathology images

Jan. TW patent issued-I753521

Jan. TW patent issued-I753448

2021

Dec.Third Prize-2021 Microsoft The Making of IoT Hackers

Dec.MetaLite 3D digital pathology image analysis software product launch

Nov.The 20th Business Startup Award-MOEA

Nov.Gold Award-Entrepreneur Warrior Competition

Oct.Future Technology Award-MOST

Sep. TW patent issued-I750686

Aug.Set up in Hsinchu Biomedical Science Park

Jul.Recruited by Asia America Multi-Technology Association

Apr.Publication in AACR2021-3D pathology imaging for lung cancer PD-L1 diagnosis

Mar.Publication in FOM2021-3D pathology imaging for breast cancer 3D immunoscoring

Mar.Publication in USCAP2021-3D pathology imaging for prostate cancer morphology diagnosis

Mar.Pre-A run fundraising completed

Feb.Tumor 3D pathology image AI analysis module completed

2020

Nov.Final 8-Beyond BioMed Accelerator Competition

Oct.3D pathology image cloud computation platform prototype completed

Jul.MetaLite 3D pathology image analysis software prototype completed

Apr.Publication in Drug Delivery-Detection of drug penetration in lung cancer spheroids using JelloX 3D imaging technology

Mar.High speed intellent scanner JelloScope prototype completed

Jan.JX ACE 3D pathology image analysis product launch

2019

Dec.Academic Entrepreneur Pioneer Award-MOST

Nov.Final 10-Deep Tech Challenge

Nov.IAPS Award

Oct.Edge computer prototype completed

Jul.Set up at NTHU Innovative Incubation Center

Jun.Angel fundraising completed

Apr.Star of Future Investment-MOST iCANiCAN

2018

Dec.Gold award-MOE Biotech Innovative Startup Competition

Nov.JelloX Biotech Inc. startup with seed fundraising

2017

Jul.Startup team building-MOST valuation creation project